FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34940711000001105: Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105936901000001113 Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110902301000001114 Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has NHS dm+d (dictionary of medicines and devices) freeness indicator Preservative free true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Is a Ciprofloxacin 2mg/ml ear drops 0.25ml unit dose preservative free 15 unit dose true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has AMP Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has specific active ingredient Ciprofloxacin hydrochloride true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has dispensed dose form Conventional release ear drops true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cetraxal 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 5 x 3 x 0.25ml unit doses Has unit of administration drop false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start